| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ORIGINAL ARTICLES |
From the Departments of Psychiatry (A.H., J.L.V.-B), Endocrinology (J.A.A., M.T.G.-U., L.P.), and Internal Medicine (J.G.-M.), University Hospital Marqués de Valdecilla, Santander, Spain.
Address reprint requests to: Andrés Herrán, MD, Clinical and Social Psychiatry Research Unit, Department of Psychiatry, University Hospital Marqués de Valdecilla, Avda. de Valdecilla s/n, 39008, Santander, Spain. Email: herran{at}humv.es
OBJECTIVE: Bone mineral density is decreased in patients with depressive disorder. This study evaluated biochemical bone remodeling markers in patients having their first depressive episode who had not taken psychotropic medications to evaluate possible pathogenic mechanisms implicated in the loss of bone mineral density in early states of this illness.
METHODS: Serum osteocalcin, parathyroid hormone, bone alkaline phosphatase, telopeptide, collagen type I C-terminal propeptide, cross-laps, and 25-hydroxyvitamin D levels were measured in 19 depressive patients and 19 age-matched healthy women. In addition, serum cortisol and interleukin-6 were determined. Patients were assessed with the Schedules for Clinical Assessment in Neuropsychiatry interview and met criteria for a single depressive episode.
RESULTS: Depressed patients had increased levels of osteocalcin (p = .003), an osteoblastic marker; telopeptide (p = .01), an osteoclastic marker; and cross-laps (p = .000), another osteoclastic marker. Parathyroid hormone was lower in patients (p = .02), whereas the rest of the markers were comparable between patients and healthy control subjects. Serum cortisol was higher in depressed patients than in control subjects (p = .003), but cortisolemia and interleukin-6 did not show any relationship with bone markers in patients. Clinical severity of the illness and weight loss due to depression in patients did not correlate with bone remodeling markers.
CONCLUSIONS: These data suggest that an increase in bone remodeling not due to vitamin D deficiency induces a release of calcium from bone and inhibition of parathyroid hormone secretion.
Key Words: depressive disorder • bone density • bone remodeling markers • osteoporosis.
Abbreviations: BMD = bone mineral density; CV = coefficient of variation; ICD-10 = International Classification of Diseases, 10th revision; IL-6 = interleukin-6; PTH = parathyroid hormone; RIA = radioimmunoassay.
This article has been cited by other articles:
 |
|
 |
|
  W. J. G. Hoogendijk, P. Lips, M. G. Dik, D. J. H. Deeg, A. T. F. Beekman, and B. W. J. H. Penninx Depression Is Associated With Decreased 25-Hydroxyvitamin D and Increased Parathyroid Hormone Levels in Older Adults Arch Gen Psychiatry, May 1, 2008; 65(5): 508 - 512. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. G. Kahl, W. Greggersen, S. Rudolf, B. M. Stoeckelhuber, C. U. Bergmann-Koester, L. Dibbelt, and U. Schweiger Bone mineral density, bone turnover, and osteoprotegerin in depressed women with and without borderline personality disorder. Psychosom Med, September 1, 2006; 68(5): 669 - 674. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. A. Milliken, J. Wilhelmy, C. J. Martin, N. Finkenthal, E. Cussler, L. Metcalfe, T. A. Guido, S. B. Going, and T. G. Lohman Depressive symptoms and changes in body weight exert independent and site-specific effects on bone in postmenopausal women exercising for 1 year. J. Gerontol. A Biol. Sci. Med. Sci., May 1, 2006; 61(5): 488 - 494. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Konstantynowicz, H. Kadziela-Olech, M. Kaczmarski, R. M. D. Zebaze, S. Iuliano-Burns, J. Piotrowska-Jastrzebska, and E. Seeman Depression in Anorexia Nervosa: A Risk Factor for Osteoporosis J. Clin. Endocrinol. Metab., September 1, 2005; 90(9): 5382 - 5385. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. G. Kahl, S. Rudolf, B. M. Stoeckelhuber, L. Dibbelt, H.-B. Gehl, K. Markhof, F. Hohagen, and U. Schweiger Bone Mineral Density, Markers of Bone Turnover, and Cytokines in Young Women With Borderline Personality Disorder With and Without Comorbid Major Depressive Disorder Am J Psychiatry, January 1, 2005; 162(1): 168 - 174. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. L. Raison and A. H. Miller When Not Enough Is Too Much: The Role of Insufficient Glucocorticoid Signaling in the Pathophysiology of Stress-Related Disorders Am J Psychiatry, September 1, 2003; 160(9): 1554 - 1565. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. D. Cameron, H. Leventhal, R. R. Love, and L. J. Patrick-Miller Trait Anxiety and Tamoxifen Effects on Bone Mineral Density and Sex Hormone- Binding Globulin Psychosom Med, July 1, 2002; 64(4): 612 - 620. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
